1. Home
  2. PCRX vs TEN Comparison

PCRX vs TEN Comparison

Compare PCRX & TEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • TEN
  • Stock Information
  • Founded
  • PCRX 2006
  • TEN 1993
  • Country
  • PCRX United States
  • TEN Greece
  • Employees
  • PCRX N/A
  • TEN N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • TEN
  • Sector
  • PCRX Health Care
  • TEN
  • Exchange
  • PCRX Nasdaq
  • TEN NYSE
  • Market Cap
  • PCRX 604.7M
  • TEN 531.7M
  • IPO Year
  • PCRX 2011
  • TEN N/A
  • Fundamental
  • Price
  • PCRX $18.98
  • TEN $16.15
  • Analyst Decision
  • PCRX Buy
  • TEN Buy
  • Analyst Count
  • PCRX 10
  • TEN 2
  • Target Price
  • PCRX $26.60
  • TEN $31.00
  • AVG Volume (30 Days)
  • PCRX 933.0K
  • TEN 471.2K
  • Earning Date
  • PCRX 11-06-2024
  • TEN 02-15-2025
  • Dividend Yield
  • PCRX N/A
  • TEN 11.15%
  • EPS Growth
  • PCRX N/A
  • TEN N/A
  • EPS
  • PCRX N/A
  • TEN 5.46
  • Revenue
  • PCRX $694,957,000.00
  • TEN $836,042,000.00
  • Revenue This Year
  • PCRX $4.94
  • TEN N/A
  • Revenue Next Year
  • PCRX N/A
  • TEN $11.66
  • P/E Ratio
  • PCRX N/A
  • TEN $2.95
  • Revenue Growth
  • PCRX 4.40
  • TEN N/A
  • 52 Week Low
  • PCRX $11.16
  • TEN $15.88
  • 52 Week High
  • PCRX $35.95
  • TEN $31.48
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 54.07
  • TEN 23.03
  • Support Level
  • PCRX $18.73
  • TEN $15.88
  • Resistance Level
  • PCRX $20.34
  • TEN $16.99
  • Average True Range (ATR)
  • PCRX 1.13
  • TEN 0.64
  • MACD
  • PCRX -0.03
  • TEN -0.08
  • Stochastic Oscillator
  • PCRX 64.09
  • TEN 8.23

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About TEN TSAKOS ENERGY NAVIGATION

Tsakos Energy Navigation Ltd is a seaborne transportation service provider for crude oil and petroleum products. The company's carriers cater to national and international independent oil companies and refiners. It generates revenue through charter contracts with its clients, which include time, bareboat, and voyage charters, contracts of affreightment, and pool arrangements.

Share on Social Networks: